Literature DB >> 1411288

Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study.

A G Røseth1, M K Fagerhol, E Aadland, H Schjønsby.   

Abstract

This study describes methods for extraction and quantification of calprotectin (L1 protein) in feces by enzyme immunoassay. This protein is a prominent antimicrobial component of neutrophils, monocytes, macrophages, and squamous epithelia. Calprotectin was stable in feces during storage for 7 days at room temperature. Small fecal samples taken from a 24-h feces collection gave a reliable estimate of calprotectin. Within-assay precision was 1.9%, and between-assay precision 14.8%. In healthy subjects (n = 33) median fecal calprotectin was 2025 micrograms/l and in hospital controls (n = 40) 10,500 micrograms/l. Median values in patients with Crohn's disease (n = 21) was 43,000 micrograms/l and in ulcerative colitis (n = 17) 40,000 micrograms/l. Fecal calprotectin was significantly correlated to fecal alpha 1-antitrypsin in the patients with Crohn's disease. Ten of 11 patients with gastrointestinal carcinomas had calprotectin level above the suggested reference limit of 6740 micrograms/l.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1411288     DOI: 10.3109/00365529209011186

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  183 in total

1.  Effect of Pentavac and measles-mumps-rubella (MMR) vaccination on the intestine.

Authors:  B Thjodleifsson; K Davídsdóttir; U Agnarsson; G Sigthórsson; M Kjeld; I Bjarnason
Journal:  Gut       Date:  2002-12       Impact factor: 23.059

2.  Histopathological parameters as predictors for the course of Crohn's disease.

Authors:  Frauke Bataille; Frank Klebl; Petra Rümmele; Rainer H Straub; Peter Wild; Jürgen Schölmerich; Ferdinand Hofstädter
Journal:  Virchows Arch       Date:  2003-07-24       Impact factor: 4.064

3.  Serologic and laboratory markers in prediction of the disease course in inflammatory bowel disease.

Authors:  Marla Cindy Dubinsky
Journal:  World J Gastroenterol       Date:  2010-06-07       Impact factor: 5.742

4.  Fecal Calprotectin: Diagnostic Accuracy of the Immunochromatographic CalFast Assay in a Pediatric Population.

Authors:  Oriano Radillo; Lorella Pascolo; Stefano Martelossi; Sara Dal Bo; Alessandro Ventura
Journal:  J Clin Lab Anal       Date:  2016-02-15       Impact factor: 2.352

5.  Fecal calprotectin and elastase 1 determinations in patients with pancreatic diseases: a possible link between pancreatic insufficiency and intestinal inflammation.

Authors:  Raffaele Pezzilli; Alessandra Barassi; Antonio M Morselli-Labate; Lorenzo Fantini; Paola Tomassetti; Davide Campana; Riccardo Casadei; Sergio Finazzi; Gianvico Melzi d'Eril; Roberto Corinaldesi
Journal:  J Gastroenterol       Date:  2007-09-25       Impact factor: 7.527

Review 6.  Host response to Clostridium difficile infection: Diagnostics and detection.

Authors:  Elena A Usacheva; Jian-P Jin; Lance R Peterson
Journal:  J Glob Antimicrob Resist       Date:  2016-09-20       Impact factor: 4.035

7.  Calprotectin as a diagnostic tool for inflammatory bowel diseases.

Authors:  Marianthi Chatzikonstantinou; Panagiotis Konstantopoulos; Spyros Stergiopoulos; Konstantinos Kontzoglou; Christos Verikokos; Despina Perrea; Dimitris Dimitroulis
Journal:  Biomed Rep       Date:  2016-09-07

8.  Consecutive Monitoring of Fecal Calprotectin and Lactoferrin for the Early Diagnosis and Prediction of Pouchitis after Restorative Proctocolectomy for Ulcerative Colitis.

Authors:  Takayuki Yamamoto; Takahiro Shimoyama; Takuya Bamba; Koichi Matsumoto
Journal:  Am J Gastroenterol       Date:  2015-04-28       Impact factor: 10.864

9.  Fecal markers of inflammation used as surrogate markers for treatment outcome in relapsing inflammatory bowel disease.

Authors:  Michael Wagner; Christer G B Peterson; Peter Ridefelt; Per Sangfelt; Marie Carlson
Journal:  World J Gastroenterol       Date:  2008-09-28       Impact factor: 5.742

10.  Enantiomers of flurbiprofen can distinguish key pathophysiological steps of NSAID enteropathy in the rat.

Authors:  T Mahmud; S Somasundaram; G Sigthorsson; R J Simpson; S Rafi; R Foster; I A Tavares; A Roseth; A J Hutt; M Jacob; J Pacy; D L Scott; J M Wrigglesworth; I Bjarnason
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.